|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.00 CZK | -0.41% |
|
-2.02% | -28.82% |
| 06-15 | Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25/04/25 | Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
Company Valuation: Pilulka Lékárny
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Market Cap 1 | 4,212 | 1,639 | 665.8 | 291 |
| Change | - | -61.1% | -59.37% | -56.3% |
| Enterprise Value (EV) 1 | 4,141 | 1,618 | 732 | 329.2 |
| Change | - | -60.93% | -54.76% | -55.02% |
| P/E | - | -25.2x | -3.81x | -2.31x |
| PBR | - | 11.7x | 20.3x | -3.1x |
| PEG | - | - | -0x | 0.1x |
| Capitalization / Revenue | 1.77x | 0.67x | 0.31x | 0.22x |
| EV / Revenue | 1.74x | 0.66x | 0.34x | 0.25x |
| EV / EBITDA | 497x | -54.3x | -5.82x | -3.65x |
| EV / EBIT | -296x | -33.9x | -4.93x | -3x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | -25.76 | -64.63 | -46.46 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 2,380 | 2,447 | 2,132 | 1,304 |
| EBITDA 1 | 8.327 | -29.82 | -125.7 | -90.27 |
| EBIT 1 | -13.99 | -47.67 | -148.6 | -109.9 |
| Net income 1 | -25.5 | -64.94 | -174.9 | -125.7 |
| Net Debt 1 | -71.61 | -20.67 | 66.16 | 38.28 |
| Reference price 2 | 1,685.00 | 650.00 | 246.00 | 107.50 |
| Nbr of stocks (in thousands) | 2,500 | 2,521 | 2,707 | 2,707 |
| Announcement Date | 04/04/23 | 04/04/23 | 29/05/24 | 25/04/25 |
1CZK in Million2CZK
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 15.79M | |
| 17.4x | 0.7x | 11.12x | -.--% | 14.93B | |
| 21.18x | 1.05x | 16.21x | -.--% | 7.08B | |
| 16.37x | 0.71x | 7.41x | 2.08% | 5.72B | |
| 12.74x | 0.81x | 5.83x | 3.37% | 3.62B | |
| 16.11x | 0.98x | 7.32x | 4.01% | 3.38B | |
| 15.07x | 1.27x | 7.73x | 5.49% | 3.37B | |
| 12.73x | 0.51x | 4.09x | 5.32% | 2.79B | |
| 41.39x | - | - | - | 2.69B | |
| Average | 19.12x | 0.86x | 8.53x | 2.89% | 4.84B | |
| Weighted average by Cap. | 18.39x | 0.83x | 9.94x | 1.74% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PINK Stock
- Valuation Pilulka Lékárny
Select your edition
All financial news and data tailored to specific country editions
